CD274 and neoplasm: In tumor clusters, SL@PB exerts catalytic and lysosomal escapeeffects, easily enhancing siRNA delivery and thus downregulating PD-L1.Catalysis also promotes the release of tumor-associated antigens (TAAs),including neoantigens and damage-associated molecular patterns.